Navigation Links
Health Network Laboratories (HNL) Enters Into License Agreement With Hunter Laboratories to Provide HunterHeart Cardiovascular Disease Management Program.
Date:5/25/2010

ALLENTOWN, Pa. and CAMPBELL, Calif., May 25 /PRNewswire/ -- HunterHeart offers physicians and patients sophisticated risk characterization and personalized therapy guidelines for cardiovascular disease.  HNL will be performing a battery of advanced tests, offering an accompanying nutrition program, and wellness coaching.  Gerry Weiss, MD, Hunter's Medical Director stated:  "With appropriate risk characterization and treatment, cardiovascular disease can be prevented for many patients and MI and stroke events can be significantly reduced."

"HNL's reputation for quality, service and innovation is exceptional.  Hunter is delighted to be working with HNL to reduce cardiovascular disease in PA and NJ," stated Chris Riedel, Hunter's CEO.  HNL's President and CEO, David G. Beckwith Ph.D., stated that, "The HunterHeart program will assist our physicians in delivering comprehensive cardiovascular health advice to their patients, and establishes HNL as a center of excellence for preventive cardiology."

About Health Network Laboratories

Based in Allentown, Pennsylvania, Health Network Laboratories (HNL) is a multi-regional medical laboratory with technologically advanced facilities in Pennsylvania and New Jersey.  HNL serves the need of the public and health care communities performing almost 6 million clinical and pathology tests each year.  HNL is consistently rated highly by physicians and clients in all areas of laboratory performance and customer satisfaction.

HNL offers a full complement of clinical laboratory and anatomic pathology services, including highly specialized esoteric testing to hospitals, physicians, long-term and assisted living facilities, businesses and government agencies.  For more information, visit http://www.healthnetworklabs.com/

About Hunter Labs, Inc.

Hunter Laboratories is the largest locally owned and operated clinical reference laboratory in northern California.  HunterHeart is one of Hunter's proprietary disease detection and management programs that are being rolled-out across the U.S.  Hunter's Incelldx mRNA test for cervical cancer detection is also being introduced across the U.S.  This test is the only accurate HPV method for women under 30, and has better specificity for predicting CIN2/CIN3 on biopsy.  For more information, visit http://www.hunterlabs.com/.


'/>"/>
SOURCE Hunter Laboratories
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures
2. Perrigo Company to Present at the Citi Investment Research Global Health Care Conference
3. Higher Education Leaders Receive TCWF Champions of Health Professions Diversity Award
4. AstraZeneca Donates $1 Million for Christiana Care Health Systems Wilmington Hospital Project
5. Bayer HealthCare Pharmaceuticals, Inc. Announces Results of a Phase 3 Clinical Trial of Gadobutrol
6. Home Health Monitoring May Significantly Improve Blood Pressure Control, Kaiser Permanente Study Finds
7. Accuray Incorporated to Present at Citi Global Health Care Conference
8. Isis Pharmaceuticals to Present at the 2010 Citi Investment Research Global Health Care Conference
9. Inverness Medical Innovations to Attend the Citi Global Health Care Conference on May 26, 2010
10. Medco to Present at the 2010 Citi Investment Research Global Health Care Conference
11. WellPoint Is First Health Benefits Company to Release CER Guidelines for Use in Evaluating Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... and SAN CLEMENTE, Calif. , June 24, ... -based mobile pulmonary function testing company, is now able to perform ... developed by ndd Medical Technologies , Inc. ... in hospital-based labs.  Thanks to ndd,s EasyOne PRO ® , ARL ... can get any needed testing done in the comfort of her ...
(Date:6/24/2016)... According to a new market ... Needles, Safety Pen Needles), Needle Length (4mm, 5mm, 6mm, ... of Purchase (Retail, Non-Retail) - Trends & Global Forecasts ... market for the forecast period of 2016 to 2021. ... by 2021 from USD 1.65 Billion in 2016, growing ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica Scruggs ... for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs surgery, ... Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, MD, ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency ... named Dr. Sesan Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. ... Director of our new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director ...
(Date:6/25/2016)... ... 25, 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the ... to iHire in recognition of their exemplary accomplishments in worksite health promotion. , The ... Health & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one ...
(Date:6/24/2016)... ... ... Those who have experienced traumatic events may suffer from a complex set ... drug or alcohol abuse, as a coping mechanism. To avoid this pain and suffering, ... traumatic event. , Trauma sufferers tend to feel a range of emotions, from depression, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Sessions in Dallas that it will receive two significant new grants to support ... as PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists ...
Breaking Medicine News(10 mins):